Attack, flare-up, or exacerbation? The terminology preferences of patients with severe asthma
Affiliation
National Health and Medical Research Council Centre of Excellence in Severe Asthma , Newcastle , AustraliaIssue Date
2019
Metadata
Show full item recordAbstract
Background: People with severe asthma experience frequent life-threatening acute asthma events. A Lancet commission recently highlighted that terms "exacerbations" and "flare-ups" are seen to trivialize these episodes and recommended use of the term "attacks." Clinicians however, preferentially use the term "exacerbation" and some guidelines recommend the use of "exacerbation" with patients. Objective: This descriptive qualitative study aimed to understand the patient's experience and perspectives of these events and language used to describe them. Methods: Semi-structured one-on-one interviews were conducted in Australia and the UK in 18 people with severe asthma and 10 with mild-moderate asthma regarding their usage and preferences for such terminologies. Additionally, nine people with severe asthma participated in two focus groups in which use of preferred terminology was explored. Results: Mean age of participants was 57?±?14.03?yr and 65% were female. A total 67 quotes were recorded in which 16 participants with severe asthma spontaneously used either the term "attack," "flare-up" and/or "exacerbation." Of these quotes, all 16 participants used "attack," one used all three terms and two used both "exacerbation" and "attack." The term "attack" was used to describe frightening events having major impacts on participant's lives, whereas "exacerbation" and "flare-up" were used to refer to both severe and mild, transient asthma-related events. Conclusion: Usage of the term "attack" was preferred by patients with severe asthma. Adoption of this language may assist in patient-clinician communication and disease management and outcomes. Wider stakeholder engagement is needed to confirm this suggestion. Abbreviations FEV1 forced expiratory volume in 1?second ATS American Thoracic Society ERS European Respiratory Society ACQ Asthma Control Questionnaire ICS inhaled corticosteroids OCS oral corticosteroids BTS British Thoracic Society SIGN Scottish Intercollegiate Guidelines Network WAP written action plan.Citation
Jones KA, Gibson PG, Yorke J, Niven R, Smith A, McDonald VM. Attack, flare-up, or exacerbation? The terminology preferences of patients with severe asthma. J Asthma. 2019 Sep 16:1-10.Journal
Journal of AsthmaDOI
10.1080/02770903.2019.1665064PubMed ID
31490698Additional Links
https://dx.doi.org/10.1080/02770903.2019.1665064Type
ArticleLanguage
enae974a485f413a2113503eed53cd6c53
10.1080/02770903.2019.1665064
Scopus Count
Collections
Related articles
- Patient and physician asthma deterioration terminology: results from the 2009 Asthma Insight and Management survey.
- Authors: Blaiss MS, Nathan RA, Stoloff SW, Meltzer EO, Murphy KR, Doherty DE
- Issue date: 2012 Jan-Feb
- Exasperations" of asthma: a qualitative study of patient language about worsening asthma.
- Authors: Vincent SD, Toelle BG, Aroni RA, Jenkins CR, Reddel HK
- Issue date: 2006 May 1
- Nocturnal temperature-controlled laminar airflow device for adults with severe allergic asthma: the LASER RCT.
- Authors: Kapoor M, Storrar W, Balls L, Brown TP, Mansur A, Hedley E, Jones T, Roberts C, Shirkey B, Dutton S, Luengo-Fernandez R, Little M, Dewey A, Marshall S, Fogg C, Boughton K, Rahman N, Yu LM, Bradding P, Howarth P, Chauhan AJ
- Issue date: 2019 Jun
- Renaming COPD exacerbations: the UK respiratory nursing perspective.
- Authors: Mwasuku C, King J, Russell REK, Bafadhel M
- Issue date: 2021 Sep 23
- Ability of Serum IgE Concentration to Predict Exacerbation Risk and Benralizumab Efficacy for Patients with Severe Eosinophilic Asthma.
- Authors: Jackson DJ, Humbert M, Hirsch I, Newbold P, Garcia Gil E
- Issue date: 2020 Feb